Which has better valuation and earnings, CAMT or ALMR?

Camtek has higher revenue and earnings than Alamar Biosciences. Alamar Biosciences is trading at a lower price-to-earnings ratio than Camtek, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Camtek $496.07M 13.40 $50.72M $0.87 163.79 Alamar Biosciences $87.16M 20.63 -$120.60M -$1.74 N/A

Does the media prefer CAMT or ALMR?

In the previous week, Camtek and Camtek both had 2 articles in the media. Camtek's average media sentiment score of 0.33 beat Alamar Biosciences' score of 0.00 indicating that Camtek is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Camtek 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to AVTR or ALMR?

In the previous week, Avantor had 4 more articles in the media than Alamar Biosciences. MarketBeat recorded 6 mentions for Avantor and 2 mentions for Alamar Biosciences. Avantor's average media sentiment score of 1.08 beat Alamar Biosciences' score of 0.00 indicating that Avantor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avantor 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ST or ALMR?

In the previous week, Sensata Technologies had 4 more articles in the media than Alamar Biosciences. MarketBeat recorded 6 mentions for Sensata Technologies and 2 mentions for Alamar Biosciences. Sensata Technologies' average media sentiment score of 1.03 beat Alamar Biosciences' score of 0.00 indicating that Sensata Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensata Technologies 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TXG or ALMR?

In the previous week, 10x Genomics had 7 more articles in the media than Alamar Biosciences. MarketBeat recorded 9 mentions for 10x Genomics and 2 mentions for Alamar Biosciences. 10x Genomics' average media sentiment score of 0.96 beat Alamar Biosciences' score of 0.00 indicating that 10x Genomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ALMR or MIR?

In the previous week, Mirion Technologies had 5 more articles in the media than Alamar Biosciences. MarketBeat recorded 7 mentions for Mirion Technologies and 2 mentions for Alamar Biosciences. Mirion Technologies' average media sentiment score of 1.19 beat Alamar Biosciences' score of 0.00 indicating that Mirion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mirion Technologies 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Alamar Biosciences (ALMR) Competitors

$25.94 0.00 (0.00%)

As of 07/2/2026 04:00 PM Eastern

Compare

ALMR vs. CAMT, AVTR, ST, TXG, and MIR

Should you buy Alamar Biosciences stock or one of its competitors? MarketBeat compares Alamar Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alamar Biosciences include Camtek (CAMT), Avantor (AVTR), Sensata Technologies (ST), 10x Genomics (TXG), and Mirion Technologies (MIR). These companies are all part of the "measuring and control equipment" industry.

How does Alamar Biosciences compare to Camtek?

Camtek (NASDAQ:CAMT) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Camtek currently has a consensus price target of $174.33, indicating a potential upside of 22.34%. Alamar Biosciences has a consensus price target of $30.00, indicating a potential upside of 15.65%. Given Camtek's higher probable upside, equities analysts plainly believe Camtek is more favorable than Alamar Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Camtek	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Camtek has higher revenue and earnings than Alamar Biosciences. Alamar Biosciences is trading at a lower price-to-earnings ratio than Camtek, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Camtek	$496.07M	13.40	$50.72M	$0.87	163.79
Alamar Biosciences	$87.16M	20.63	-$120.60M	-$1.74	N/A

Camtek has a net margin of 9.63% compared to Alamar Biosciences' net margin of 0.00%. Camtek's return on equity of 22.26% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Camtek	9.63%	22.26%	11.70%
Alamar Biosciences	N/A	N/A	N/A

41.9% of Camtek shares are held by institutional investors. 79.4% of Camtek shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Camtek and Camtek both had 2 articles in the media. Camtek's average media sentiment score of 0.33 beat Alamar Biosciences' score of 0.00 indicating that Camtek is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Camtek	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Camtek beats Alamar Biosciences on 12 of the 14 factors compared between the two stocks.

How does Alamar Biosciences compare to Avantor?

Avantor (NYSE:AVTR) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

In the previous week, Avantor had 4 more articles in the media than Alamar Biosciences. MarketBeat recorded 6 mentions for Avantor and 2 mentions for Alamar Biosciences. Avantor's average media sentiment score of 1.08 beat Alamar Biosciences' score of 0.00 indicating that Avantor is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avantor	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alamar Biosciences has lower revenue, but higher earnings than Avantor. Alamar Biosciences is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55B	1.07	-$530.20M	-$0.81	N/A
Alamar Biosciences	$87.16M	20.63	-$120.60M	-$1.74	N/A

95.1% of Avantor shares are owned by institutional investors. 0.3% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Alamar Biosciences has a net margin of 0.00% compared to Avantor's net margin of -8.42%. Avantor's return on equity of 9.95% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avantor	-8.42%	9.95%	4.78%
Alamar Biosciences	N/A	N/A	N/A

Avantor currently has a consensus target price of $10.47, indicating a potential upside of 1.70%. Alamar Biosciences has a consensus target price of $30.00, indicating a potential upside of 15.65%. Given Alamar Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Alamar Biosciences is more favorable than Avantor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	3 Sell rating(s)	12 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.94
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Avantor beats Alamar Biosciences on 9 of the 15 factors compared between the two stocks.

How does Alamar Biosciences compare to Sensata Technologies?

Sensata Technologies (NYSE:ST) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

In the previous week, Sensata Technologies had 4 more articles in the media than Alamar Biosciences. MarketBeat recorded 6 mentions for Sensata Technologies and 2 mentions for Alamar Biosciences. Sensata Technologies' average media sentiment score of 1.03 beat Alamar Biosciences' score of 0.00 indicating that Sensata Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensata Technologies	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sensata Technologies currently has a consensus target price of $47.80, suggesting a potential upside of 5.41%. Alamar Biosciences has a consensus target price of $30.00, suggesting a potential upside of 15.65%. Given Alamar Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Alamar Biosciences is more favorable than Sensata Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensata Technologies	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

99.4% of Sensata Technologies shares are owned by institutional investors. 0.7% of Sensata Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sensata Technologies has a net margin of 1.28% compared to Alamar Biosciences' net margin of 0.00%. Sensata Technologies' return on equity of 18.23% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensata Technologies	1.28%	18.23%	7.34%
Alamar Biosciences	N/A	N/A	N/A

Sensata Technologies has higher revenue and earnings than Alamar Biosciences. Alamar Biosciences is trading at a lower price-to-earnings ratio than Sensata Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensata Technologies	$3.70B	1.78	$31.30M	$0.31	146.28
Alamar Biosciences	$87.16M	20.63	-$120.60M	-$1.74	N/A

Summary

Sensata Technologies beats Alamar Biosciences on 11 of the 14 factors compared between the two stocks.

How does Alamar Biosciences compare to 10x Genomics?

10x Genomics (NASDAQ:TXG) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

84.7% of 10x Genomics shares are held by institutional investors. 8.8% of 10x Genomics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Alamar Biosciences has a net margin of 0.00% compared to 10x Genomics' net margin of -3.55%. Alamar Biosciences' return on equity of 0.00% beat 10x Genomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
10x Genomics	-3.55%	-2.86%	-2.23%
Alamar Biosciences	N/A	N/A	N/A

10x Genomics has higher revenue and earnings than Alamar Biosciences. 10x Genomics is trading at a lower price-to-earnings ratio than Alamar Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
10x Genomics	$642.82M	7.70	-$43.54M	-$0.17	N/A
Alamar Biosciences	$87.16M	20.63	-$120.60M	-$1.74	N/A

In the previous week, 10x Genomics had 7 more articles in the media than Alamar Biosciences. MarketBeat recorded 9 mentions for 10x Genomics and 2 mentions for Alamar Biosciences. 10x Genomics' average media sentiment score of 0.96 beat Alamar Biosciences' score of 0.00 indicating that 10x Genomics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
10x Genomics	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

10x Genomics presently has a consensus price target of $25.92, suggesting a potential downside of 33.56%. Alamar Biosciences has a consensus price target of $30.00, suggesting a potential upside of 15.65%. Given Alamar Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Alamar Biosciences is more favorable than 10x Genomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
10x Genomics	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

10x Genomics and Alamar Biosciences tied by winning 7 of the 14 factors compared between the two stocks.

How does Alamar Biosciences compare to Mirion Technologies?

Alamar Biosciences (NASDAQ:ALMR) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

Mirion Technologies has higher revenue and earnings than Alamar Biosciences. Alamar Biosciences is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alamar Biosciences	$87.16M	20.63	-$120.60M	-$1.74	N/A
Mirion Technologies	$925.40M	4.70	$28.80M	$0.10	173.70

In the previous week, Mirion Technologies had 5 more articles in the media than Alamar Biosciences. MarketBeat recorded 7 mentions for Mirion Technologies and 2 mentions for Alamar Biosciences. Mirion Technologies' average media sentiment score of 1.19 beat Alamar Biosciences' score of 0.00 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mirion Technologies	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alamar Biosciences currently has a consensus price target of $30.00, indicating a potential upside of 15.65%. Mirion Technologies has a consensus price target of $27.13, indicating a potential upside of 56.16%. Given Mirion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Mirion Technologies is more favorable than Alamar Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

78.5% of Mirion Technologies shares are held by institutional investors. 6.3% of Mirion Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Mirion Technologies has a net margin of 2.56% compared to Alamar Biosciences' net margin of 0.00%. Mirion Technologies' return on equity of 6.44% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alamar Biosciences	N/A	N/A	N/A
Mirion Technologies	2.56%	6.44%	3.48%

Summary

Mirion Technologies beats Alamar Biosciences on 15 of the 16 factors compared between the two stocks.

Get Alamar Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALMR vs. The Competition

Export

Metric	Alamar Biosciences	Lab Analytical Instruments Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$1.80B	$1.80B	$5.20B	$12.48B
Dividend Yield	N/A	N/A	16.11%	6.52%
P/E Ratio	-14.91	N/A	23.91	24.70
Price / Sales	20.63	20.63	171.59	98.05
Price / Cash	N/A	N/A	35.06	57.09
Price / Book	N/A	N/A	13.25	6.46
Net Income	-$120.60M	N/A	$113.80M	$337.01M
7 Day Performance	-2.74%	-2.74%	0.93%	1.69%
1 Month Performance	26.29%	26.29%	1.08%	3.81%
1 Year Performance	N/A	N/A	10.03%	23.90%

Alamar Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALMR Alamar Biosciences	2.1369 of 5 stars	$25.94 flat	$30.00 +15.7%	N/A	$1.80B	$87.16M	N/A	222
CAMT Camtek	4.0678 of 5 stars	$153.72 -8.5%	$174.33 +13.4%	+54.5%	$7.17B	$496.07M	176.69	400	News Coverage Gap Up
AVTR Avantor	1.9684 of 5 stars	$10.30 +2.1%	$10.47 +1.7%	-25.8%	$7.02B	$6.55B	N/A	13,500
ST Sensata Technologies	3.9115 of 5 stars	$46.73 -5.0%	$47.80 +2.3%	+40.8%	$6.81B	$3.70B	150.75	16,700	News Coverage Positive News Analyst Upgrade Gap Up
TXG 10x Genomics	1.7955 of 5 stars	$36.75 +2.9%	$24.00 -34.7%	+199.8%	$4.67B	$642.82M	N/A	1,240	Analyst Forecast High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALMR) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alamar Biosciences (ALMR) Competitors

ALMR vs. CAMT, AVTR, ST, TXG, and MIR

How does Alamar Biosciences compare to Camtek?

Summary

How does Alamar Biosciences compare to Avantor?

Summary

How does Alamar Biosciences compare to Sensata Technologies?

Summary

How does Alamar Biosciences compare to 10x Genomics?

Summary

How does Alamar Biosciences compare to Mirion Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALMR vs. The Competition

Alamar Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alamar Biosciences (ALMR) Competitors

ALMR vs. CAMT, AVTR, ST, TXG, and MIR

How does Alamar Biosciences compare to Camtek?

Do analysts prefer CAMT or ALMR?

Which has better valuation and earnings, CAMT or ALMR?

Is CAMT or ALMR more profitable?

Do institutionals & insiders have more ownership in CAMT or ALMR?

Does the media prefer CAMT or ALMR?

Summary

How does Alamar Biosciences compare to Avantor?

Does the media refer more to AVTR or ALMR?

Which has better earnings and valuation, AVTR or ALMR?

Do institutionals and insiders believe in AVTR or ALMR?

Is AVTR or ALMR more profitable?

Do analysts rate AVTR or ALMR?

Summary

How does Alamar Biosciences compare to Sensata Technologies?

Does the media prefer ST or ALMR?

Do analysts prefer ST or ALMR?

Do institutionals & insiders hold more shares of ST or ALMR?

Is ST or ALMR more profitable?

Which has stronger earnings & valuation, ST or ALMR?

Summary

How does Alamar Biosciences compare to 10x Genomics?

Do institutionals and insiders hold more shares of TXG or ALMR?

Is TXG or ALMR more profitable?

Which has preferable valuation & earnings, TXG or ALMR?

Does the media refer more to TXG or ALMR?

Do analysts prefer TXG or ALMR?

Summary

How does Alamar Biosciences compare to Mirion Technologies?

Which has preferable earnings & valuation, ALMR or MIR?

Does the media prefer ALMR or MIR?

Do analysts recommend ALMR or MIR?

Do institutionals and insiders have more ownership in ALMR or MIR?

Is ALMR or MIR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALMR vs. The Competition

Alamar Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools